Aerovate Therapeutics Readies $100 Million IPO Effort
magicmine/iStock via Getty Images
Quick Take
Aerovate Therapeutics (AVTE) has filed to raise $100 million in an IPO of its common stock, according to an S-1/A registration statement.
The firm is a clinical stage biopharma developing a treatment for cardiopulmonary…
